One year later, patient remained asymptomatic on maintenance dose of EnteraGam ® 5 g QD.
Over 4 months, erythrocyte sedimentation decreased from initial measurement of 90 to 11 mm/h; white blood cell count decreased from 12,400/μL to 10,900/μL; hemoglobin increased from 10.9 to 12.4 g/dL; hematocrit increased from 34.7% to 38.0%; platelet count decreased from 482x10 3 /μL to 248x10 3 /μL; and serum albumin concentration increased from 4.1 to 4.5 mg/dL. Stool frequency increased to 10 to 15 watery stools per day with frequent bleeding for approximately 3 weeks.
EnteraGam ® 5 g QID therapy added to steroid therapy after patient refused biologic therapy and high-dose IV corticosteroids.
